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Abstract
One of the heat shock family protein (Hsp) expressing bacteria is the gram negative, periodontal pathogen Aggregatibacter
actinomycetemcomitans (Aa). A. actinomycetemcomitans’ Hsp is a 64-kDa GroEL-protein, which has been shown to influence
the host cells. In this study we used recombinant A. actinomycetemcomitans GroEL (rAaGroEL) protein as a model antigen to
study GroEL-mediated T cell immune response. Human peripheral mononuclear cells (PBMCs), when stimulated with
recombinant rAaGroEL, expressed early activation marker CD69 and IL-2R (CD25). CD25 and CD69 expressions were higher
in CD4+ T cells compared to CD8+ T cells. rAaGroEL-responding CD4+ T cells expressed IL-10, IFNc and TNFa cytokines.
Interestingly, there were also IL-10 and IFNc double cytokine producing CD4+ T cells. Additionally, IFNc expressing CD4+ T
cells were also T-bet positive. Altogether the results suggest that rAaGroEL protein affects CD4+ T cells to differentiate into
IFNc IL10-secreting T-bet+ Th1 cells.
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Introduction
Heat shock proteins (Hsps) are a group of proteins with highly
conserved sequence similarity among species from bacteria to
human [1]. Apart from their well-known role in protein folding,
bacterial Hsp60 can modulate immune system cells to manipulate
host immune response. One of the GroEL (also called Hsp60)
expressing bacteria is a periodontal pathogen A. actinomycetemcomi-
tans which retains its antigenic property after deleting well-
characterized virulence factors [2]. This observation indicates that
AaGroEL might affect human T cell function.
Bacterial Hsp60s such as AaGroEL can have a potential to
modulate immune system cells. In fact there are reports in the
literature that support the potential role of bacterial GroEL as an
immunomodulator. For instance, in Helicobacter pylori-infected
human patients, T cells were activated in response to H. pylori
hsp60, to secrete IFNc and IL-10. However, the origin of IL-10
was not reported [3]. Brucella abortus recombinant GroEL protein
primed CD4+ T cells in vaccinated mice proliferated and the
proliferating cells produce IL-2 and IFNc in T cell culture
supernatants [4]. After immunisation of BALB/c mice with
Brucella abortus GroEL heat-hock gene, splenic T cells produced
high level of IFNc suggesting Th1 response [5]. Furthermore,
recombinant hsp60 of Salmonella typhi immunized mice also showed
higher IFNc and IL-2 levels when splenocytes were cultured with
GroEL [6]. These studies suggest that bacterial GroEL induces
Th1 type immune response. However, some of these studies did
not measure the cytokine expression with cell surface associated
phenotypic markers. As a result, the origin of cytokines is not well
characterized. Thus, It is important to unravel the T cells that
specifically secret these cytokines. Furthermore, none of these
studies show GroEL responding CD4+ T cells can be double
cytokine producing Th1 cells.
In this study, we used recombinant AaGroEL protein as a
model antigen to study bacterial Hsp-mediated CD4+ T cell
immune response. To this extent, human peripheral blood
mononuclear cells were cultured with rAaGroEL and cytokine
profiles of CD4+ T cells were measured. Our data suggested that
rAaGroEL-responding CD4+ T cells have the capacity to
differentiate into IFNc IL-10 producing Tbet+ Th1 cells. Thus,
to our best knowledge, our data first time demonstrated that
bacterial recombinant GroEL protein of A. actinomycetemcomitans
polarized periferal blood CD4+ T cells into IFNc IL-10 double
cytokine producing T-bet+ Th1 cells.
Materials and Methods
Human Peripheral Blood Mononuclear Cells
Ethics approval for this study was obtained from the Dokuz
Eylu¨l University, I
N
zmir, Turkey. All blood donors participated in
this study were systemically and periodontally healthy adult
volunteers. Subjects were asked to sign an informed consent that
was previously approved by the Bioethics Committee of Dokuz
Eylu¨l University. Venous blood was drawn from the volunteers.
Peripheral blood mononuclear cells (PBMC) were isolated by
Ficoll-Hypaque density gradient centrifugation [7].
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Preparation of Recombinant AaGroEL
The genomic sequence of 64-kDa AaGroEL was first cloned
into pGEM T Easy (Promega) vector [8] and then transferred into
pET28a+ (Novagen) expression vector [9]. The confirmed pET/
AaGroEL vector was transformed into BL21 (DE3) E.coli cells for
protein expression. The protein purification from cell extract was
carried out with TALON Cell Thru Resin according to the
manufacturer’s instructions (Clontech). The purity and concen-
tration of the eluted protein was confirmed by 8% SDS-PAGE and
Bradford Protein Assay (Bio-Rad) respectively. The protein
identity was further confirmed with western blotting and MS
analysis. Possible LPS contamination of purified protein sample
was checked by using LAL chromogenic endpoint assay (Hycult
Biotechnology). Detoxi-gel endotoxin removing gel (Thermo,
Fisher Scientific Inc) was used to remove LPS contamination of
rAaGroEL purified samples according to manufacture instruc-
tions.
Stimulation of Peripheral Mononuclear Cells
PBMCs were cultured at a concentration of 26106 cells/mL in a
volume of 500 ml. Cells were incubated at different time points (2–
96 h) with or without stimulants at 37uC in a humidified incubator
with 5% CO2. The medium consisted of RPMI-1640 supple-
mented with 10% fetal bovine serum (FBS) (Gibco), 100 units/mL
penicillin, 100 pg/mL streptomycin (Biochrom AG) and 25 mM
HEPES buffer (Gibco). The purifed rAaGroEL (1–40 mg/ml),
PMA (25 ng/ml) in the presence of Ionomycin (1 mg/ml) or PHA
(1 mg/ml) (Biochrom AG) as positive controls and elution buffer
and medium alone as negative controls were used to stimulate the
cells. Each set of culture condition in all experiments was carried
out as triplicates. The recombinant AaGroEL protein used in this
study was expressed in E.coli. Therefore to address LPS
contamination, we monitored TNFa expression of CD4+ T cells
in different culture conditions including purified-rAaGroEL, LPS-
removed-purified-rAaGroEL, purified-rAaGroEL-treated with
Proteinase K and heat-inactivated-proteinase K-treated-rAa-
GroEL.
Phenotypic Characterization of Cells
PBMCs were stimulated with various concentration of recom-
binant AaGroEL as well as negative and positive controls and were
labeled with selected combination of cell surface antibodies
including anti-CD3, anti-CD4, anti-CD8, anti-CD14, anti-CD25
and anti-CD69 (BD Biosciences). Cell surface labeling was carried
Figure 1. GroEL protein induces T cells activation. (A) Overexpression of rAaGroEL in E.coli cells. M: Marker, E.coliCE/rAaGroEL: rAaGroEL
overexpressed E.coli lysate, and purified rAaGroEL: purified rAaGroEL protein by using Talon Resin. (B) A. actinomycetemcomitans sonic extract (AaCE),
recombinant E.coli GroEL, purified rAaGroEL protein was confirmed with western blot by using anti-GroEL antibody of E.coli. (C) show representative
flow data of CD69 expressing T cells. (D) Expression of CD69 by T cells. Human PBMCs cultured 48 h with a various rAaGroEL doses (1–40 mg/ml),
RPMI and Elution Buffer (EB) which is used for rAaGroEL purification. At 48 h, cells were labeled anti-CD3 and anti-CD69 antibodies. CD3+ and non-
CD3 cells were gated and analyzed for their CD69 expression. Data are representative of 3 experiments with different donors. Error bars represent
standard deviation and *indicates p,0.05.
doi:10.1371/journal.pone.0049252.g001
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Figure 2. GroEL protein preferentially activates CD4+ T cells. Following 24 h and 48 h stimulation of PBMCs with rAaGroEL (20 mg/ml), cells
were labeled with anti-CD3, anti-CD4, anti-CD8, anti-CD69 and anti-CD25 antibodies. CD8+ and CD4+ gated T cells were analyzed for CD69 and CD25
expressions. (A) CD69 expression of CD4+ and CD8+ T cells at 24 h and 48 h. (B) CD25 expression of CD4+ and CD8+ T cells at 24 h and 48 h. (C)
Representative distribution of PBMCs and CD69 and CD25 expressing rAaGroEL responding CD4+ T cells. Data are representative of experiments with
cells from 3 donors. Error bars represent standard deviation and *indicates p,0.05.
doi:10.1371/journal.pone.0049252.g002
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out according to manufacturer’s instructions (BD Biosciences).
Labeled cells were acquired by FACSArray and analyzed by
FACSArray software or FlowJo.
Intracellular Cytokine or Transcription Factor Detection
The PMBC cultures were carried out as described above except
for intracellular cytokine staining. To detect intracellular cyto-
kines, 4 hours prior to the predetermined culture time, BD
GolgistopTM (1:1500) (BD Biosciences) was added to the cultures.
At the end of the culture time, cells were first labeled with cell
surface markers for T cells. Then cells were fixed and
permeabilized. Following that antibodies for cytokines or tran-
scription factors were added to cells. Labeled cells were analyzed
by Flow cytometry.
Statistical Analysis
The samples acquired by FACSArray and data were analyzed
by FACSArray system software, FlowJo and FCAP softwares. Flow
data were exported to MS Office Excel for further analysis. A two-
tailed student’s t test was used for statistical analysis and p,0.05
accepted as statistically significant.
Results
rAaGroEL Protein Activates Human CD4+ T Lymphocytes
The antigenic stimulation of T lymphocytes induces expression
of CD69, the earliest activation marker [10]. In order to
investigate the antigenic effect of rAaGroEL on T lymphocytes,
the CD69 expression was monitored on CD3+ T cells. We first
cloned and over-expressed 64-kDa AaGroEL protein in E.coli.
GroEL protein was purified (Fig. 1A) and the identity of protein
was confirmed by Western blot (Fig. 1B). PBMCs were cultured
with rAaGroEL at different concentration (1–40 mg) and at
different time points. At 48 h, the CD69 expression was increased
in a dose dependent manner and its expression on CD3+ T cells
was highest when rAaGroEL was used at 20 mg/ml (Fig. 1C–D).
Thus, 20 mg/ml concentration of rAaGroEL was determined as
the optimum dose for activation of T lymphocytes and used for all
subsequent screenings.
To identify whether rAaGroEL preferentially targets CD4+ or
CD8+ T cells, rAaGroEL stimulated cells were analyzed
simultaneously for CD69 and CD25 (IL-2R) expression [11] on
the surface of CD4+ and CD8+ T cells. The CD4+ T cells
expressed high level of CD69 molecules compared to CD8+ T
Figure 3. GroEL responding CD4+ T cells express IFNc, IL-10, TNFa and T-bet. PBMCs cultured from 24 h to 96 h with rAaGroEL (20 mg/ml).
RPMI and PMA/I or PMA were used as negative and positive controls respectively. At indicated time points CD4 cell surface staining was performed.
Then, cytokine antibodies (IFNc, IL10, TNFa and T-bet) were added. Cells were acquired and analyzed. For each molecule analysis, cells were gated for
CD4+ T cells. (A), (B), (C), (D) shows time kinetics of IFNc, IL-10, TNFa and T-bet expression among CD4+ T cells with controls. Data are representative
of 3 experiments. Error bars represent standard deviation and *represents p,0.05.
doi:10.1371/journal.pone.0049252.g003
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cells (Fig. 2A). CD25 expression was increased CD4+ T cells in a
time dependent manner but there was no detectable change in
CD8+ T cells (Fig. 2B). Figure 2C shows representative
distribution of PBMCs (percentage of CD14+, CD8+, CD4+
and other cells) and CD69 and CD25 expressing rAaGroEL
responding CD4+ T cells. Data suggested that CD4+ T cells
significantly increased both CD25 and CD69 expression (Fig. 2A–
C), suggesting preferential targeting of CD4+ T cells by
rAaGroEL. Thus, monitoring of CD4+ T cells response was
pursued in greater details.
rAaGroEL Responding CD4+ T Cells Express IFNc, IL-10,
TNFa and T-bet
Human CD4+ T cells can differentiate into at least four major
subsets, Th1 [12], Th2 [13], Th9 [14] and Th17 [15] cells. After
detecting the activated CD4+ T cells in the rAaGroEL-stimulated
cultures, the phenotype of cytokine producing cells was investi-
gated to determine which T cell subset differentiation is induced.
Each Th subset produces their unique set of cytokines. IFNc as
Th1 phenotype major cytokine [13] was measured in rAaGroEL-
stimulated cultures. Data showed that at 48 h, IFNc expression
reached up to 10% (p,0.05) and the level of IFNc stayed elevated
at 9.5% (p,0.05) at 96 h in rAaGroEL-stimulated cells (Fig. 3A).
IL-10 was first discovered in Th2 T-cells that inhibits cytokine
production [16] but it has recently been shown to be produced by
many cells including CD4+ T cells [17]. We next investigated
whether rAaGroEL-responding cells expressed IL-10. IL-10-
expressing CD4+ T cells increased up to 12% in rAaGroEL-
stimulated cells compared to 3% (p,0.05) (4-fold increase) in
negative controls at 96 h (Fig. 3B). TNFa is an important pro-
inflammatory cytokine and secreted by immune cells including
T cells [18]. Whether rAaGroEL-responding CD4+ T cells
express TNFa was also investigated. TNFa expressing CD4+ T
cells in rAaGroEL-stimulated cultures increased from 2% up to
11% (5.5-fold increase) at 96 h compared to negative controls
(Fig. 3C). Detecting IFNc and IL-10 cytokines producing CD4+ T
cells suggest that AaGroEL may commit CD4+ T cells into Th1
phenotype. It was previously reported that T-bet is a transcription
factor that plays a role in Th1 lineage commitment by activating
IFN-c [19]. Thus, we hypothesized that if rAaGroEL-responsive
CD4+ T cells are polarized into Th1 subset, they should be
expressing T-bet. Data showed that T-bet expression continuously
increased and reached 9% (Fig. 3D) compare to 0.2% in negative
control cultures at 72 h.
rAaGroEL Responding T Cells Concurrently Express IFNc
and IL-10
IFNc is a major product of Th1 cells. Interestingly, many IFNc-
producing Th1 cells were found to produce IL-10 which is an anti-
inflammatory cytokine in antimicrobial immune responses [20,21].
To further investigate whether IL-10 and IFNc cytokines were
concurrently expressed by the same CD4+ T cells, IL-10 and
IFNc cytokines were measured at the same time. Data showed that
IL-10 IFNc expressing CD4+ T cells gradually increased up to 7%
Figure 4. GroEL responding CD4+ T cells double cytokine producers. PBMCs cultured from 24 h to 96 h with rAaGroEL (20 mg/ml). RPMI and
PMA/I were used as negative and positive controls respectively. At indicated time points CD4 cell surface staining was performed. Then, IFNc, IL10
and T-bet antibodies were added to fixed and permed cells. Cells were acquired and analyzed. For each molecule analysis, cells were gated for CD4+
T cells. (A) shows representative distribution of IFNc+IL-10+ double positive T cells, (B) shows representative distribution IFNc+T-bet+ double positive
T cells. (C) and (D) show representative flow data of double cytokine producing CD4+ T cells.
doi:10.1371/journal.pone.0049252.g004
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at 72 h in rAaGroEL-stimulated cultures. rAaGroEL responding
CD4+ T cells were IL-10 and IFNc double cytokine producing T
cells (Fig. 4A). Additionally, 6% of IFNc-expressing CD4+ T cells
also expressed T-bet transcription factor at 72 h (Fig. 4B).
Figure 4C–D shows representative flow data of double cytokine
producing CD4+ T cells.
rAaGroEL Activity is not due to LPS Contamination
The recombinant AaGroEL protein used in this study was
expressed in E.coli. Therefore, the possibility that T cell activation
or cytokine stimulating activity of rAaGroEL was due to LPS
contamination was addressed. To that extent, we monitored
TNFa expression in different culture condition, because rAa-
GroEL protein induced continuous expression of TNFa (Fig. 3C).
Firstly, rAaGroEL was obtained from crude extract and LPS was
removed from the purified rAaGroEL samples by using Poly B
supported resin. Then, cells were cultured with purified rAa-
GroEL, LPS-removed-rAaGroEL and TNFa was measured
among CD4+ T cells. Data showed that rAaGroEL-stimulated
cells increased TNFa expression among CD4+ T cells and non-
CD4 lymphocytes compared to negative controls. There were no
significant differences in TNFa expression in purified-rAaGroEL
or LPS-removed purified- rAaGroEL-stimulated cells (Fig. 5A).
Additionally, purified-rAaGroEL treated with Proteinase K or
heat-inactivated-proteinase K-treated-rAaGroEL- samples were
cultured with cells. Results showed that there was a loss of TNFa
stimulating function in Proteinase K-treated-rAaGroEL stimulated
cells as compared to only rAaGroEL-stimulated cells (Fig. 5B).
Altogether, these findings suggest that TNFa expression among
CD4+ T cells was not due to LPS contamination (Fig. 4A and B).
Discussion
The interest in the antigenic properties of bacterial Hsps comes
from their ability to affect human host cells. It is known that
different bacterial Hsps can induce inflammatory responses [22].
As a bacterial Hsp A. actinomycetemcomitans GroEL protein’s effect
on immune system cells has not been studied yet. In this work,
differentiation capacities of recombinant A. actinomycetemcomitans
GroEL protein on human T lymphocytes were investigated.
AaGroEL was cloned, expressed and purified. Then, recombinant
AaGroEL was used as antigen source. To our best knowledge
presented data demonstrated for the first time that rAaGroEL
polarizes peripheral blood CD4+ T cells into an IFNc IL-10
double cytokine producing T-bet+ Th1 phenotype.
Firstly, we showed that rAaGroEL-responding CD4+ T cells
more successfully upregulate their CD69 and CD25 expression
compared to CD8+T cells, suggesting that rAaGroEL could
Figure 5. GroEL activity on CD4+ T cells is not due to LPS contamination. In order to test if the function came from possible LPS
contamination, PMBCs were cultured with various antigens. (A) PBMCs were stimulated with rAaGroEL (20 mg/ml), LPS-removed-rAaGroEL (20 mg/ml;
LPS was removed using Poly B supported resin). After 48 h stimulation cells were first labeled with CD4 antibodies. The cells, then, were fixed and
permeabilized and incubated with anti-TNFa. Representative flow data shows TNFa expression among CD4+ T and non-CD4T cells. (B) PBMCs were
incubated with rAaGroEL, Proteinase K-treated-rAaGroEL, heat-inactivated-Proteinase-K-treated-rAaGroEL and medium alone for 48 h and TNFa
expression was measured. Representative flow data shows TNFa expression among CD4+ T and non-CD4T cells.
doi:10.1371/journal.pone.0049252.g005
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activate CD4+ T cells more effectively than CD8+T. Nevertheless,
H. pylori hsp60 (also called HspB)-stimulated PBMCs showed
proliferative responses but expression of activation markers IL-2R
and HLA-DR on CD4+ and CD8+T cells were the same in
infected and uninfected individuals [3]. Our finding suggests that
different bacterial Hsp60s might affect T cells differently.
Brucella abortus GroEL heat-shock gene induces Th1 immune
response. However, in this study soluble IFNc and IL-4 cytokines
were measured in mouse heterogeneous splenocytes but not IL-10
[5]. Additionally, Oliveira et al. showed that recombinant Brucella
abortus GroEL protein primed T cells’ cytokine profile was
characteristic of a Th1 type based on the detection of IL-2 and
IFNc [4]. Furthermore, recombinant GroEL of Salmonella typhi
immunized mice shifted the immune response toward Th1
phenotype where higher levels of IFNc and IL-2 were detected
[6]. However, these studies did not measure the intracellular
cytokine expression with CD4 cell surface associated phenotypic
marker, meaning the origin of cytokines is not well characterized.
Thus, it is important to unravel the T cells that specifically secret
these cytokines. Furthermore, none of these studies show GroEL
responding CD4+ T cells can be double cytokine producing Th1
cells. It is important to point out presented study showed that
recombinant GroEL protein of A. actinomycetemcomitans mediates
IFNc IL-10 double cytokine producing Th1 phenotype from
CD4+ T cells.
Professional antigen presenting cells (APCs), appropriate TCRs
for antigens, costimulatory and cytokine signals are required for
CD4+ T cells to become activate. When T cells can become
activated, they can proliferate and differentiate into different T
helper (Th) subsets. Previously reported Th subsets are Th1 [12],
Th2 [13], Th9 [14] and Th17 [15]. Th cells are named by their
unique cytokine expression and carry out distinct effector
functions. For instance, IFNc is produced mainly by NK cells
and T cells including Th1 cells. IL-10 was first discovered in Th2
cells. It was found that IL-10 is also produced by human Th1 T
cells [17]. To investigate possible outcome of CD4+ T cell
activation by rAaGroEL, whether CD4+ T cells differentiate into
Th1 or not, phenotype specific cytokines were concurrently
measured with CD4 cell surface marker on same T cells. Data
showed that rAaGroEL-stimulated CD4+ T lymphocytes ex-
pressed significant level of IFNc (Fig. 3A) and IFNc-expressing
CD4+ T cells were also expressing T-bet transcription factor
(Fig. 4B and D). Morever, rAaGroEL-responding CD4+ T cells
gradually increased their IL-10 expression (Fig. 3B). More
importantly, IFNc and IL-10 cytokines were simultaneously
expressed on same CD4+ T cells in response to rAaGroEL
(Fig. 4A and C). Taken together, the results obtained from this
study elucidated that rAaGroEL-responding CD4+ T cells
differentiated into IFNc IL-10 expressing Tbet+ Th1 effector T
cells.
IFNc and IL-10 producing CD4+ T cell clones were first
obtained in active tuberculosis patients [23] and patients with
Lyme disease [24]. It is thus interesting that recombinant
AaGroEL protein-mediated CD4+ T immune response polarized
into IFNc and IL-10 double cytokine producing Tbet+ Th1 cells.
It was recently demonstrated that IFNc IL-10 producing Th1 cells
possess regulatory and effector functions. Th1 cells themselves are
source of IL-10 that controls immune responses. Th1 effector
responses are regulated through a negative feedback loop via the
co-induction of IL-10 in addition to IFNc in the same cells
suggesting self control mechanisms of Th1 cells [25].
In this study, it was shown for first time that rAaGroEL-
responding- CD4+ T were IL-10 and IFNc double cytokine
producing cells. These cells were also Tbet+. We concluded that
rAaGroEL-responding CD4+ T cells differentiated into IL-10
IFNc-expressing Tbet+ Th1 cells. Thus, an immune regulatory
effect of recombinant AaGroEL on human T cells shown in this
study would advance our understanding of Aggregatibacter actinomy-
cetemcomitans-GroEL mediated immune response in inflammatory
diseases.
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